For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Acea Biosciences, Inc.

USPTO Granted Patents = 49

CIPO Patents = 6

EPO Patents = 14

Trademarks = 18

Forward Citations = 824

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Xiaobo Wang (47 out of 81 patents)

Xiao Xu (39 out of 56 patents)

Yama A Abassi (28 out of 34 patents)

4. Biao Xi (12 out of 20 patents)

5. Nan Li (12 out of 19 patents)

6. Li Zhao (8 out of 15 patents)

7. Josephine Atienza (8 out of 8 patents)

8. Long Mao (6 out of 25 patents)

9. Wen Fu Zhang (5 out of 7 patents)

10. Tianxing Wang (5 out of 7 patents)

11. Ye Chen (5 out of 39 patents)

12. Naichen Yu (5 out of 5 patents)

13. Jiangbo Gan (4 out of 5 patents)

14. Haoyun An (4 out of 22 patents)

15. Jian Wu (3 out of 30 patents)

Core Competencies:

Cell-Substrate Impedance

Real-Time Electronic Cell Sensing

Impedance-Based Cell Profiling

G-Protein Coupled Receptor

Receptor Tyrosine Kinase

Flow Cytometry

Cardiomyocyte Monitoring

Electroporation-Based Delivery

Heterocyclic Compounds

Cytotoxicity Profiling

Oncogene Addicted Targets

Dynamic Monitoring

49 patents: Sort by Forward Citations

1. 10725023 - Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways for the treatment of cancer (2020-07-28),

2. 10690677 - Real time electronic cell sensing systems and applications for cell-based assays (2020-06-23),

3. 10648913 - System and method for detecting multiple-excitation-induced light in a flow channel (2020-05-12),

4. 10620188 - Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways (2020-04-14),

5. 10551371 - System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function (2020-02-04),

6. 10539523 - System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties (2020-01-21),

7. 10533985 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2020-01-14),

8. 10261080 - Optical detection system for flow cytometer, flow cytometer system and methods of use (2019-04-16),

9. 10234392 - Optical engine for flow cytometer, flow cytometer system and methods of use (2019-03-19),

10. 10215748 - Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways (2019-02-26),

11. 10168318 - Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways (2019-01-01),

12. 10067121 - Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology (2018-09-04),

13. 10018581 - Impedance based devices and methods for use in assays (2018-07-10),

14. 10012636 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2018-07-03),

15. 9920074 - Heterocyclic compounds and uses thereof (2018-03-20),

ACEA Biosciences, Inc. is a leading biotechnology company focused on providing innovative cell analysis solutions for life science research and drug discovery. Their cutting-edge technology includes xCELLigence real-time cell analysis and NovoCyte flow cytometry systems, which enable scientists to study cell behavior with high sensitivity and precision. By combining advanced hardware, software, and consumables, ACEA Biosciences aims to accelerate the pace of scientific discovery and contribute to advances in personalized medicine, regenerative medicine, and cancer research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

49 Patents

#120 in San Diego, CA

#1,641 in California

#6,913 in US

#13,864 in the World

San Diego, CA, United States of America

Acea Biosciences, Inc.

Forward Citations = 824

33 inventors:

Xiaobo Wang (47 out of 81 patents)

Xiao Xu (39 out of 56 patents)

Yama A Abassi (28 out of 34 patents)

4. Biao Xi (12 out of 20 patents)

5. Nan Li (12 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…